Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;11(5):377-384.
doi: 10.1212/CPJ.0000000000001066.

Epilepsy Treatment Complacency in Patients, Caregivers, and Health Care Professionals

Patricia E Penovich  1 , John M Stern  1 , Danielle A Becker  1 , Lucretia Long  1 , Nancy Santilli  1 , Lynanne McGuire  1 , Eugenia Y Peck  1
Affiliations

Epilepsy Treatment Complacency in Patients, Caregivers, and Health Care Professionals

Patricia E Penovich et al. Neurol Clin Pract. 2021 Oct.

Abstract

Objective: To explore the perspectives of adult patients with epilepsy, caregivers, and health care professionals (HCPs) on treatment for seizures and treatment decisions, we developed and administered the STEP Survey (Seize the Truth of Epilepsy Perceptions).

Methods: Participants were recruited from online panel M3 and by Rare Patient Voice and completed the self-administered online STEP Survey. Analysis of variance and chi-square tests were used for group comparisons.

Results: The STEP Survey was completed by 400 adult patients, 201 caregivers, and 258 HCPs. Patients estimated reporting 45% of their seizures to their HCP, whereas caregivers estimated 83% and HCPs estimated 73% were reported. The most common reason for not reporting seizures was that the seizures were not serious enough to mention (patients 57%; caregivers 66%). A minority of patients (25%) and caregivers (30%) were very or extremely likely to ask their HCP about changing antiseizure medication (ASM) in the next 12 months. The HCP was most frequently selected by patients, caregivers, and HCPs as the person who initiates discussion of changing ASMs (patients 73%/caregivers 66%/HCPs 75%) and increasing ASM dosage (patients 77%/caregivers 68%/HCPs 81%). A majority of patients (65%) and caregivers (68%) somewhat or strongly agreed that they do not change ASMs due to fear of getting worse. HCPs perceive this fear less often, stating that 50% of their patients feel afraid when a second ASM was added.

Conclusions: Improved reporting of all seizures, discussion of treatment changes, and the impact of fear on treatment decisions provide opportunities to reduce complacency and optimize patient outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Reasons Patients and Caregivers Did Not Report All Seizures to Health Care Professionals
Total n (patients + caregivers) = 151.
Figure 2
Figure 2. Likelihood of Asking Health Care Professionals About Treatment Changes in the Next 12 Months
Figure 3
Figure 3. Discussion of Surgeries for Epilepsy Among HCPs, Patients, and Caregivers
ap < 0.05 vs patients. bp < 0.05 vs caregivers. HCP = health care professionals; NA = not applicable; RNS = responsive neurostimulation.
Figure 4
Figure 4. Patient, Caregiver, and HCP Perspectives on a Patient Treatment Map Telling Them to See an Epileptologist/Specialist as Soon as They Have Symptoms
HCP = health care professional. Survey question: how important is it that the following program be implemented in the future: a patient treatment map that tells patients and caregivers to see an epileptologists/specialist as soon as they have symptoms, not wait for a long time. Percentages are the sum of respondents who selected the rating on a 5-point Likert scale ranging from 1 = not at all important to 5 = extremely important.
Figure 5
Figure 5. Patients and Caregivers Report of Fear of Having a Seizure in Diverse Situations
Percentages are the sum of respondents who reported very or extremely afraid on a 5-point Likert scale ranging from 1 = not at all afraid to 5 = extremely afraid.
See this image and copyright information in PMC

References

    1. Glauser T, Ben-Menachem E, Bourgeois B, et al. . ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094–1120. - PubMed
    1. Glauser T, Ben-Menachem E, Bourgeois B, et al. . Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551–563. - PubMed
    1. Westover MB, Cormier J, Bianchi MT, et al. . Revising the “Rule of Three” for inferring seizure freedom. Epilepsia. 2012;53:368–376. - PMC - PubMed
    1. Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279–286. - PMC - PubMed
    1. Tian N, Boring M, Kobau R, Zack MM, Croft JB. Active epilepsy and seizure control in adults - United States, 2013 and 2015. MMWR Morb Mortal Wkly Rep. 2018;67:437–442. - PMC - PubMed